Monday, December 20, 2010 9:21:57 PM
Recent FENC News
- Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024 • GlobeNewswire Inc. • 05/07/2024 10:15:00 PM
- Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/21/2024 10:00:00 AM
- Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024 • GlobeNewswire Inc. • 03/19/2024 10:01:00 AM
- Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand • PR Newswire (US) • 03/18/2024 07:00:00 AM
- Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand • GlobeNewswire Inc. • 03/18/2024 01:00:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 03/06/2024 09:07:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:04:59 PM
- Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results • GlobeNewswire Inc. • 02/29/2024 12:04:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 03:47:17 PM
- FDA Issues Reminder of Non-Substitution of PEDMARK® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin • GlobeNewswire Inc. • 02/01/2024 10:55:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:24:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/05/2024 09:45:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/04/2024 09:42:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 09:30:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/28/2023 08:51:07 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/18/2023 05:15:11 AM
- Fennec Announces Incremental $5 Million Investment from Petrichor • GlobeNewswire Inc. • 12/05/2023 10:55:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/16/2023 09:05:27 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/09/2023 09:56:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:52:31 PM
- Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/09/2023 09:50:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/09/2023 09:38:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/08/2023 11:19:45 PM
- Fennec Pharmaceuticals Announces Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/06/2023 10:59:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/03/2023 09:19:04 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM